Transcription Factor ASCL1 Acts as a Novel Potential Therapeutic Target for the Treatment of the Cushing's Disease.
Chen Z, Jia Q, Zhao Z, Zhang Q, Chen Y, Qiao N, Ye Z, Ji C, Zhang Y, He W, Shi C, Cai Y, Yao B, Han R, Wang Y, Shou X, Shen M, Cao X, Zhou X, Cheng H, Zhu J, Hu Y, Zhang Z, Ye H, Li Y, Li S, Wang Y, Ma Z, Ni T, Zhao Y.
Chen Z, et al. Among authors: cai y.
J Clin Endocrinol Metab. 2022 Jul 14;107(8):2296-2306. doi: 10.1210/clinem/dgac280.
J Clin Endocrinol Metab. 2022.
PMID: 35521682